Johnson and Johnson considers 20 billion dollar sale of its orthopedics business

Johnson and Johnson is exploring a potential sale of its DePuy Synthes orthopedics unit for over 20 billion dollars. Major buyout firms are showing interest.

洞察:
Johnson & Johnson is preparing a potential sale of its DePuy Synthes orthopedics unit, according to reports on February 19, 2026. Bloomberg News reported that the unit could be valued at more than $20 billion and that big buyout firms are already circling the business. The company has been planning to separate the DePuy Synthes unit, and a sale at this scale would be a major corporate divestiture with significant financial and ownership implications for Johnson & Johnson.
An undated rendering shows a concept of a new Johnson & Johnson cell therapy facility to be built in Pennsylvania, U.S. Johnson & Johnson/Handout via REUTERS THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. NO RESALES. NO ARCHIVES. MANDATORY CREDIT. IN-FRAME LABEL AND LOGO FROM SOURCE
An undated rendering shows a concept of a new Johnson & Johnson cell therapy facility to be built in Pennsylvania, U.S. Johnson & Johnson/Handout via REUTERS THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. NO RESALES. NO ARCHIVES. MANDATORY CREDIT. IN-FRAME LABEL AND LOGO FROM SOURCE
IUX24

IUX24 提供深度財經、經濟與投資資訊,藉助 AI 發掘全球市場中最重要的信號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場數據、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易信號或經紀服務。投資涉及風險,用戶在作出投資決定前應審慎評估相關資訊。